f" name="ref17" id="ref17"> Chuang, Y.W., Yu, M.C., Lin, C.L., Yu, T.M., Shu, K.H. and Kao, C.H. (2015) Risk of Peripheral Arterial Occlusive Disease in Patients with Systemic Lupus Erythematosus. Medicine, 94, 1-7.
https://doi.org/10.1097/MD.0000000000002121 [18] Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatology, 40, 1725.
https://doi.org/10.1002/art.1780400928 [19] Parodis, I., Emamika, S., Gomez, A., Gunnarson, I., Van Vollenhoven, R.F. and Chatzidioniysiou (2019) Clinical SLEDAI-2K Zero May Be a Pragmatic Outcome Measure in SLE Studies. Expert Opinion on Biological Therapy, 19, 157-168.
https://doi.org/10.1080/14712598.2019.1561856 [20] Dorner, T. and Furie, R. (2019) Novel Paradigms in Systemic Lupus Erythematosus. The Lancet, 393, 2344-2358.
https://doi.org/10.1016/S0140-6736(19)30546-X [21] Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., et al. (1993) Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1000 Patients. Medicine, 72, 113-124.
https://doi.org/10.1097/00005792-199303000-00005 [22] Erdozain, J.G., Villar, I., Nieto, J. and Ruiz-Irastorza (2014) Peripheral Arterial Disease in Systemic Lupus Erythematosus: Prevalence and Risk Factors. The Journal of Rheumatology, 41, 310-317.
https://doi.org/10.3899/jrheum.130817 [23] Urowitz, M.B., Bookman, A.A., Koehler, B.E., Smythe, H.A. and Ogryzlo, M.A. (1976) The Bimodal Mortality Pattern of Systemic Lupus Erythematosus. The American Journal of Medicine, 60, 221-225.

comments powered by Disqus
WJCD Subscription
E-Mail Alert
WJCD Most popular papers
Publication Ethics & OA Statement
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.